4-hydroxyalprazolam has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertilsson, L; Carrero, JJ; Diczfalusy, U; Heimbürger, O; Lindholm, B; Molanaei, H; Odar-Cederlöf, I; Qureshi, AR; Stenvinkel, P | 1 |
1 other study(ies) available for 4-hydroxyalprazolam and Chronic Kidney Diseases
| Article | Year |
|---|---|
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
Topics: Adult; Aged; Algorithms; Alprazolam; Anti-Anxiety Agents; Biomarkers; Biotransformation; C-Reactive Protein; Cytochrome P-450 CYP3A; Female; Humans; Hydroxycholesterols; Hydroxylation; Male; Middle Aged; Orosomucoid; Renal Dialysis; Renal Insufficiency, Chronic | 2012 |